CJC-1295/Ipamorelin costs more because there are two peptides involved
But medication alone is not enough
Originally developed for type 2 diabetes management, it works by mimicking natural hunger hormones in the brain to slow down stomach emptying and curb your appetite, making it easier to stick to a calorie deficit and achieve significant, sustainable weight loss
Individuals receiving this treatment often exhibit substantial reductions in body weight, with improvements seen in both body composition and metabolic parameters
Originally approved for type 2 diabetes, with some brands later receiving approvals for obesity and obstructive sleep apnea, these drugs are also being prescribed off-label for a range of conditions
manufacturing facilities, but these are expected to come online between 2027 and 2031